Grants and Contributions:

Back to search

Title:

GenFA Training and Testing

Agreement Number:

1034864

Agreement Value:

$74,880.00

Agreement Date:

Oct 1, 2025 - Sep 30, 2026

Description:

Leaky blood vessels in the retina are the main cause of vision loss in diseases like age-related macular degeneration and diabetic retinopathy – which collectively affect 380 million individuals worldwide. While there are drugs that can stop retinal leakage, the most reliable test for detecting it involves an injection of dye and necessitates emergency readiness in case of an allergic reaction. Hence, this test is invasive, complex, costly, and infrequently used. To address this challenge, we propose an innovative artificial intelligence (AI) approach that will simulate the invasive test from a non-invasive, injection-free photograph commonly collected in routine eye exams.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Halifax, Nova Scotia, CA B3H 0A8

Reference Number:

172-2025-2026-Q2-1034864

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

788528321

Recipient Type:

For-profit organization

Recipient's Legal Name:

EMAGIX INC.

Federal Riding Name:

Halifax

Federal Riding Number:

12005

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

334512